Merrimack Pharmaceuticals, Inc. (MACK) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Cambridge, MA, United States. The current CEO is Gary L. Crocker.
MACK has IPO date of 2012-03-29, listed on the NASDAQ Global Market, a market capitalization of $223.97M.
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
